Proteinuria in Diabetic Nephropathy. Other specified diabetes mellitus with diabetic polyneuropathy
Conditions
Interventions
Intervention 1: Intervention group:This group will be given Losartan 25 mg twice a day every 12 hours as well as traditional medicine product (10 grams sachet) twice a day two hours after breakfast an
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Informed consent to enter the project People aged 30 to 70 years No kidney failure or any other disease that leads to diabetic nephropathy No symptoms of urinary tract infection during study Not taking anticoagulants, corticosteroids Excretion of albumin between 30-300 mg in 24-hour urine Blood pressure less than 160 mmHg Potassium less than 5.8 mA/L GFR more than 60 ml per minute per 1.73 m3 body Creatinine less than 2 mg/dl No professional athletes Not having Chronic neurological disease (severe depression and anxiety) Non-pregnancy and lactation SGPT rate less than three times normal before study (below 100 units per liter) HbA1C between 7 and 9% No urinary tract infection and kidney ducts.
Exclusion criteria
Exclusion criteria: Causing any complications Dissatisfaction with follow-up treatment Increase proteinuria Drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreased Proteinuria in urine. Timepoint: At the beginning of the study (before the intervention) and on days 30 after the intervention. Method of measurement: UA Urinary Protein.;Decreased Proteinuria in 24 hour Urinary protein. Timepoint: At the beginning of the study (before the intervention) and on day 60 after the intervention. Method of measurement: 24 hour Urinary Protein. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRomella Haider
Ghoum University of Medical Sciences
Outcome results
None listed